Short Interest in First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Expands By 169.2%

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 21,717 shares, a growth of 169.2% from the June 30th total of 8,067 shares. Approximately 0.2% of the company’s shares are sold short. Based on an average daily trading volume, of 43,175 shares, the days-to-cover ratio is presently 0.5 days.

First Trust NYSE Arca Biotechnology Index Fund Trading Up 1.9%

FBT traded up $4.57 during mid-day trading on Tuesday, hitting $251.31. 39,607 shares of the stock were exchanged, compared to its average volume of 126,789. The firm’s fifty day moving average is $234.59 and its two-hundred day moving average is $216.49. First Trust NYSE Arca Biotechnology Index Fund has a 1-year low of $161.30 and a 1-year high of $258.20. The company has a market cap of $2.85 billion, a PE ratio of 21.72 and a beta of 0.65.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Dynamic Wealth Strategies LLC increased its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 10.8% during the fourth quarter. Dynamic Wealth Strategies LLC now owns 515 shares of the company’s stock worth $106,000 after buying an additional 50 shares during the period. Sequent Planning LLC lifted its stake in First Trust NYSE Arca Biotechnology Index Fund by 4.5% in the first quarter. Sequent Planning LLC now owns 1,150 shares of the company’s stock worth $231,000 after acquiring an additional 50 shares during the last quarter. Kestra Private Wealth Services LLC grew its holdings in First Trust NYSE Arca Biotechnology Index Fund by 0.6% during the 4th quarter. Kestra Private Wealth Services LLC now owns 8,919 shares of the company’s stock worth $1,842,000 after acquiring an additional 53 shares in the last quarter. Signaturefd LLC grew its holdings in First Trust NYSE Arca Biotechnology Index Fund by 30.6% during the 4th quarter. Signaturefd LLC now owns 235 shares of the company’s stock worth $49,000 after acquiring an additional 55 shares in the last quarter. Finally, HF Advisory Group LLC increased its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 5.0% in the 2nd quarter. HF Advisory Group LLC now owns 1,270 shares of the company’s stock valued at $315,000 after purchasing an additional 60 shares during the last quarter.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.